Clinical Trials on Primary Breast Cancer in New Zealand

Total 13764 results

Weill Medical College of Cornell University

Completed

Comparison of Paravertebral Block With General Anesthesia in Patients Undergoing Breast Cancer Surgery

Breast Cancer

United States
German Breast Group
Roche Pharma AG

Recruiting

Neoadjuvant Endocrine Therapy +/- the PI3K Inhibitor Inavolisib in HER2+, HR+, PIK3CA Mutant Early Breast Cancer (GeparPiPPa)

HER2-positive Breast Cancer

Germany
Rutgers, The State University of New Jersey
National Cancer Institute (NCI)

Terminated

Phase I/II Study of Weekly Abraxane and RAD001 in Women With Locally Adv. or Metastatic Breast Ca

Breast Cancer

United States
Christchurch Hospital

Unknown

How Does the Diabetes Drug, Pioglitazone, Reduce Protein Loss in the Urine?

Diabetes Mellitus, Type 2

New Zealand
Celgene Corporation

Withdrawn

Study of Amrubicin With or Without Herceptin in Patients With Metastatic Breast Cancer

Metastatic Breast Cancer

United States
Montefiore Medical Center
Albert Einstein College of Medicine; Deciphera Pharmaceuticals LLC

Terminated

Rebastinib Plus Antitubulin Therapy With Paclitaxel or Eribulin in Metastatic Breast Cancer

Breast Cancer | Stage IV Breast Cancer | Recurrent Breast Carcinoma | Human Epidermal Growth Factor 2 Negative Carcinoma of Breast | Breast Adenocarcinoma

United States
Memorial Sloan Kettering Cancer Center

Active, not recruiting

A Study of the Use of Text Message Reminders to Take Palbociclib

Breast Cancer

United States
Novartis Pharmaceuticals

Recruiting

Study to Assess the Safety of Alpelisib Plus Fulvestrant, in Men and Post-menopausal Women With HR-positive, HER2-negative, Advanced Breast Cancer (aBC) With PIK3CA Mutation, Whose Disease Progressed on or After Endocrine Treatment (ALPINIST)

Advanced Breast Cancer

India
Eisai Inc.
Halozyme Therapeutics

Terminated

Study of Eribulin Mesylate in Combination With PEGylated Recombinant Human Hyaluronidase (PEGPH20) Versus Eribulin Mesylate Alone in Subjects With Human Epidermal Growth Factor Receptor 2 (HER2)-Negative, High-Hyaluronan (HA) Metastatic Breast Cancer (MBC)

Metastatic Breast Cancer

United States
Gilead Sciences

Completed

Efficacy and Safety of Tenofovir Alafenamide (TAF) Versus Tenofovir Disoproxil Fumarate (TDF)-Containing Regimens in Participants With Chronic Hepatitis B Virus (HBV) Infection and Stage 2 or Greater Chronic Kidney Disease Who Have Received a Liver Transplant

Chronic Hepatitis B

New Zealand
ETOP IBCSG Partners Foundation

Completed

Surgical Resection With or Without Axillary Lymph Node Dissection in Treating Women With Node-Negative Breast Cancer and Sentinel Lymph Node Micrometastases (23-01)

Breast Cancer

France, Switzerland, Australia, Peru, Italy, New Zealand, Slovenia, Belgium, Brazil, Denmark
Pfizer

Completed

Treatment Patterns and Clinical Outcomes Among Talazoparib-Treated Adults With HER2-Negative mBC With gBRCA1/2m

Breast Neoplasms | Metastatic Breast Cancer

United States
Merrimack Pharmaceuticals
Sanofi

Completed

A Trial of Preoperative MM-121 With Paclitaxel in HER2-negative Breast Cancer

ER Positive, Her2 Negative Breast Cancer Patients | Triple Negative Breast Cancer Patients

United States
Bristol-Myers Squibb

Completed

Phase I Study of Dasatinib (BMS-354825) and Capecitabine for Women With Advanced Breast Cancer

Advanced Breast Cancer

United States, Spain, Italy
University Hospitals of Derby and Burton NHS Foundation...
University of Nottingham; Breast Cancer Trials, Australia and New Zealand; Sussex... and other collaborators

Active, not recruiting

POSNOC - A Trial Looking at Axillary Treatment in Early Breast Cancer (POSNOC)

Breast Cancer

United Kingdom, New Zealand, Australia
Memorial Sloan Kettering Cancer Center

Active, not recruiting

Evaluate The Accuracy Of Breast MRI Biopsy In Diagnosing A Complete Tumor Response For Some Women Following Neoadjuvant Chemotherapy For Breast Cancer

Breast Cancer

United States
Memorial Sloan Kettering Cancer Center

Completed

Multi-Beam Intensity-Modulated Radiation Therapy for Node-Positive Breast Cancer

Breast Cancer

United States
University of Medicine and Dentistry of New Jersey
National Cancer Institute (NCI)

Terminated

Epirubicin and Vinorelbine in Treating Patients With Stage II, Stage III, or Stage IV Breast Cancer

Breast Cancer

United States
Personalis Inc.

Recruiting

ctDNA Based MRD Testing for NAC Monitoring in TNBC (B-STRONGER-I)

Minimal Residual Disease | TNBC - Triple-Negative Breast Cancer

United States
Proton Collaborative Group

Recruiting

Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast Cancer

Breast Cancer | Breast Neoplasm | Breast Tumor | Cancer of the Breast

United States
Dartmouth-Hitchcock Medical Center
American Cancer Society, Inc.

Recruiting

An Observational Pilot Study to Test a Smartwatch-based EMA Method During Exercise With Breast Cancer Survivors

Breast Cancer

United States
Montefiore Medical Center

Recruiting

Pilot Study Assessing the Effect of Cyclin-dependent Kinase 4/6 Inhibitors on Body Composition in Patients With ER+/HER2- Metastatic Breast Cancer

Breast Cancer

United States
Dartmouth-Hitchcock Medical Center

Completed

The Prone to Supine Breast MRI Trial

Breast Cancer

United States
Gary Schwartz

Withdrawn

Neoadjuvant Run-In Study With TAK-228 Followed by Letrozole/TAK-228 in Women With High-Risk ER+/HER2- Breast Cancer

Breast Cancer

United States
Memorial Sloan Kettering Cancer Center

Completed

Experience of Arab American Women With Breast Cancer: In-depth Interviews

Breast Cancer

United States
Dartmouth-Hitchcock Medical Center

Completed

A Study to Evaluate the Use of Supine MRI Images in Breast Conserving Surgery

Breast Cancer

United States
Dartmouth-Hitchcock Medical Center
Dartmouth College

Completed

Proof of Principle Trial to Determine if Nutritional Supplement Conjugated Linoleic Acid (CLA) Can Modulate the Lipogenic Pathway in Breast Cancer Tissue

Breast Cancer

United States
Tulane University Health Sciences Center
Novartis; Board of Regents, State of Louisiana

Withdrawn

ERB-B4 After Treatment With HDAC Inhibitor in ER+ Tamoxifen Refractory Breast Cancer

Breast Cancer

United States
Yale University

Completed

Pilot for The Breast Cancer Endocrine Therapy Adherence (BETA) Trial

Breast Cancer

United States
Koning Corporation
University of Rochester

Completed

Koning Breast Computed Tomography Guided Neoadjuvant Treatment Monitoring

Breast Cancer

United States
Dartmouth-Hitchcock Medical Center
National Cancer Institute (NCI)

Completed

Participation Restrictions in Breast Cancer Survivors

Breast Cancer

United States
Rauscher, Gregory E., M.D. PA

Unknown

Testing Spectrosense EVA System for Detection of Breast Cancer by Analyzing Volatile Organic Compounds (VOCs) in Exhaled Air

Breast Cancer

United States
Memorial Sloan Kettering Cancer Center
The City College of New York; Ralph Lauren Center for Cancer Care and Prevention and other collaborators

Terminated

Neuropsychologic and Electrophysiological Features of Cancer-Related Cognitive Side Effects in Racial and Ethnic Minority Breast Cancer Patients

Breast Cancer

United States
Trinitas Comprehensive Cancer Center
Aptium Oncology Research Network

Unknown

Guided Relaxation Training for the Reduction of Self-Reported Stress in Individuals With Newly Diagnosed Breast Cancer (09-IM-01)

Breast Cancer

United States
GE Healthcare

Completed

Testing Digital Breast Tomosynthesis vs. Regular Mammogram in Detecting Breast Cancer in Women Having Screening Mammogram

Breast Cancer

United States
Fermiscan Ltd

Unknown

Use of Hair to Diagnose Breast Cancer

Breast Cancer

Australia
University of Medicine and Dentistry of New Jersey
National Cancer Institute (NCI)

Terminated

Ixabepilone and Hydroxychloroquine in Treating Patients With Metastatic Breast Cancer

Breast Cancer

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Recruiting

Eliminating Surgery or Radiotherapy After Systemic Therapy in Treating Patients With HER2 Positive or Triple Negative Breast Cancer

Invasive Breast Carcinoma | Estrogen Receptor Negative | HER2/Neu Negative | Progesterone Receptor Negative | Triple-Negative Breast Carcinoma | HER2 Positive Breast Carcinoma | Stage I Breast Cancer AJCC v7 | Stage IA Breast Cancer AJCC v7 | Stage IB Breast Cancer AJCC v7 | Stage II Breast Cancer AJCC... and other conditions

United States
Intuitive Surgical

Recruiting

Robotic vs. Open NSM for Early Stage Breast Cancer (SP NSM)

Breast Cancer | Breast Cancer Female | Breast | Breast Disease | Breast Cancer, Early-Onset

United States
Memorial Sloan Kettering Cancer Center

Active, not recruiting

Partial Breast Irradiation (PBI) Using 40 Gy for Select Patients With Early Invasive or Noninvasive Breast Cancer

Breast Cancer

United States
Genentech, Inc.

Completed

Safety, Tolerability, and Pharmacokinetic (PK) Study of DHES0815A in Participants With Human Epidermal Growth Factor Receptor (HER)2-Positive Breast Cancer

Breast Cancer

United States, Korea, Republic of
Columbia University
Wyeth is now a wholly owned subsidiary of Pfizer; Genentech, Inc.

Completed

Study of Temsirolimus, Erlotinib and Cisplatin in Solid Tumors

Triple Negative Breast Cancer

United States
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)

Completed

Docetaxel in Treating Older Patients With Metastatic Breast, Lung, or Prostate Cancer

Breast Cancer | Lung Cancer | Prostate Cancer

United States
NSABP Foundation Inc
Eisai Inc.

Completed

Comparison of Neoadjuvant Chemotherapy With Weekly Paclitaxel or Eribulin Followed by A/C in Women With Locally Advanced HER2-Negative Breast Cancer

Breast Cancer | HER2-negative Breast Cancer

United States, Canada
Memorial Sloan Kettering Cancer Center

Recruiting

A Study of Contrast-Enhanced Mammography (CEM) Scans in People With Breast Cancer

Breast Cancer

United States
Memorial Sloan Kettering Cancer Center

Active, not recruiting

Study Assessing the Potential for Reduced Rates of Implant Failure Using Multi-Beam Intensity-Modulated Radiation Therapy for Locally Advanced Breast Cancer Patients With Implant Reconstructions

Breast Cancer

United States
Keith D. Paulsen
Dartmouth College

Not yet recruiting

MRg-NIRS Imaging System Breast Cancer Trial (MRg-NIRS)

Breast Cancer

United States
New Mexico Cancer Care Alliance

Completed

Mathematical Modeling to Predict Response to Neoadjuvant Chemotherapy in Breast Cancer

Breast Cancer

United States
Yale University

Completed

A Randomized Controlled Trial of Routine Shave Margins Versus Standard Partial Mastectomy in Breast Cancer Patients

Breast Cancer

United States
Dartmouth-Hitchcock Medical Center

Completed

Estrogen Receptor-Positive Breast Cancer Patient-Derived Xenografts

Breast Cancer

United States

Clinical Trials on Primary Breast Cancer in New Zealand

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Finland

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations